MedPath

A Clinical trial on SEENTHIL CHOORANAM in the management ofUTHIRAVATHASURONITHAM (Rheumatoid arthritis).

Phase 2
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Registration Number
CTRI/2021/02/031274
Lead Sponsor
Government Siddha Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.SIDDHA ASPECT:- Positive findings in Uyirthathu

Udalthathu, Envagai Thervu.

2.MODERN ASPECT:- RA factor test-positive

Anti ccp test- Positive

CRP

ANA test

Exclusion Criteria

1.Other degenerating joint diseases-osteoarthritis

sero negative spondyloarthritis, ankylosing

spondylitis.

2.Infectious joint diseases like Tuberculosis ,

Chronic polyarthritis in chickungunia viral

infection.

3.Metabolic joint disease like Gout.

4.Pregnancy and lactating mother.

5.Chronic liver and renal disease patients.

6.People with RA factor negative.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Symptomatic relief - reduction in pain, swelling, movement difficulties. <br/ ><br>2. Improve the physical movements and relieve the disabilities and structural defects of hands and legs as much as possible. <br/ ><br>3.Reduce any extra articular <br/ ><br>involvement of the disease if any.Timepoint: 45 days
Secondary Outcome Measures
NameTimeMethod
1.Prevent recurrence of the disease by advising ,continuous and periodic intake of medicine and dietary regimen. <br/ ><br>2. Proper monitoring of patients and disease state with relevant blood test and immunological assays.Timepoint: 45 days
© Copyright 2025. All Rights Reserved by MedPath